Cellectar Biosciences, Inc. - CLRB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$9.07M
QoQ value delta ($000)
$0 (0.0%)
Implied price effect (QoQ)
+0.0%
Shares
Total shares
3,259,616
QoQ shares delta
-5 (0.0%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CLRB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Caligan Partners LP 1,306 469,998 0.06%
STEMPOINT CAPITAL LP 986 354,938 0.17%
VANGUARD CAPITAL MANAGEMENT LLC 910 327,367 0.0%
SILVERARC CAPITAL MANAGEMENT, LLC 894 321,728 0.09%
Bleichroeder LP 802 288,679 0.14%
Jupiter Topco LLC 759 274,156 0.0%
BALYASNY ASSET MANAGEMENT L.P. 611 220,000 0.0%
Nantahala Capital Management, LLC 611 219,998 0.02%
Empery Asset Management, LP 527 189,605 0.61%
DIADEMA PARTNERS LP 384 138,341 0.05%
Stonepine Capital Management, LLC 290 104,550 0.16%
Persistent Asset Partners Ltd 258 92,983 0.08%
BOOTHBAY FUND MANAGEMENT, LLC 236 85,069 0.0%
GEODE CAPITAL MANAGEMENT, LLC 148 53,351 0.0%
VANGUARD FIDUCIARY TRUST CO 128 46,220 0.0%
Sequoia Financial Advisors, LLC 60 21,850 0.0%
Riverview Capital Advisers, LLC 50 10,384 0.01%
ACADIAN ASSET MANAGEMENT LLC 46 16,577 0.0%
NORTHERN TRUST CORP 41 14,839 0.0%
BlackRock, Inc. 13 4,735 0.0%
UBS Group AG 8 3,093 0.0%
BARCLAYS PLC 1 561 0.0%
MORGAN STANLEY 1 510 0.0%
US BANCORP \DE\ 0 3 0.0%
DANSKE BANK A/S 0 2 0.0%